The University of Chicago Header Logo

Connection

David Grinblatt to Immunomodulation

Back to Details
This is a "connection" page, showing publications David Grinblatt has written about Immunomodulation.
David Grinblatt
Connection Strength
0.022
Immunomodulation
  1. Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas. Leuk Lymphoma. 2010 Jul; 51(7):1241-50.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.